Abstract:Background: Sepsis is mainly characterized by a dysregulated host response to infection and cytokine storm syndrome is one of the main pathogenic mechanisms of sepsis. Interleukin-3 (IL-3), a pro-inflammatory factor, has a multifaceted role in inflammatory diseases. However, its role in the pathogenesis of sepsis remains unknown.Methods: Serum levels of IL-3 were measured and analyzed in 38 Intensive Care Unit (ICU) patients with sepsis, 36 non-septic ICU patient controls, and 30 healthy volunteers. The effects of IL-3 on survival, inflammation, tissue damage, bacterial clearance, and the MAPK pathway were assessed using 2 male mouse models: cecum puncture and ligation (CLP)-induced sepsis and lipopolysaccharide (LPS)-induced sepsis.Results: Serum IL-3 levels were significantly higher in patients with sepsis on the day of diagnosis compared to ICU patient controls and healthy volunteers. Patients with septic shock showed significantly higher serum IL-3 levels compared to non-shocked patients. Serum interleukin-3 levels were correlated with sequential (sepsis-related) organ failure assessment scores (SOFA). Serum IL-3 level could discriminate septic shock from sepsis. Anti-IL-3 antibodies prolong survival time, recombinant IL-3 shortens survival time in two mouse models of CLP-induced sepsis and LPS-induced sepsis. Anti-IL-3 antibody application reduced inflammatory factor release (including IL-3, Interleukin-6 (IL-6), Interleukin1-β (IL-1β), and Tumor necrosis factor-α(TNF-α)); attenuated organ damage (including lung, liver, and kidney); enhanced bacterial clearance; attenuated splenic tissue inflammatory factor (including IL-3, IL-6, IL-1β, and TNF-α) protein content; and down-regulated phosphorylated p38, ERK, JNK protein content in MAPK pathway in lung, liver, and kidney. Recombinant IL-3 application promotes the release of inflammatory factors (including IL-3, IL-6, IL-1β, and TNF-α); exacerbates organ damage (including lung, liver, and kidney); reduces bacterial clearance; increases inflammatory factors (including IL-3, IL-6, IL-1-β, and TNF-α) protein content in splenic tissues; upregulates phosphorylated p38, ERK, JNK protein content in MAPK pathway in lung, liver, and kidney.Conclusions: Serum IL-3 levels are elevated in patients with sepsis, which may correlate with the severity of the disease. In experimental sepsis, we demonstrated that inhibition of IL-3 prolongs survival time, whereas IL-3 plays the opposite role. Anti-IL-3 may be a new target for sepsis treatment.

Exogenous C3 Protein Enhances the Adaptive Immune Response to Polymicrobial Sepsis Through Down-Regulation of Regulatory T Cells.

Exogenous C3 Postpones Complement Exhaustion and Confers Organ Protection in Murine Sepsis

The effect of human complement C3 protein applied at different times in treatment of polymicrobial sepsis

A Metabolite from Commensal Candida Albicans Enhances the Bactericidal Activity of Macrophages and Protects Against Sepsis

Effect of Interleukin-36β on Activating Autophagy of CD4+CD25+ Regulatory T Cells and Its Immune Regulation in Sepsis.

Interleukin‐38 protects against sepsis by augmenting immunosuppressive activity of CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells

Interleukin-38 protects against sepsis by augmenting immunosuppressive activity of CD4+ CD25+ regulatory T cells.

Sphingosine 1-Phosphate Receptor-3 Contributes to Host Defense Against Polymicrobial Sepsis Via Modulating Macrophage Chemotaxis (CAM4P.161)

Complement C3 depletion links to the expansion of regulatory T cells and compromises T-cell immunity in human abdominal sepsis: A prospective pilot study

Complement C5a Regulates IL‐17 by Affecting the Crosstalk Between DC and Γδ T Cells in CLP‐induced Sepsis

Increased Susceptibility of S1PR3-Deficient Mice to Escherichia Coli Sepsis is Associated with an Impaired Bactericidal Activity in Macrophage

Regulation of IL-8 Production by Complement-Activated Product, C5a, in Vitro and in Vivo During Sepsis.

Exosomes Derived from Septic Mouse Serum Modulate Immune Responses Via Exosome-Associated Cytokines.

Inhibition of Interleukin-3 Reversed the Inflammatory Response and Organ Damage Induced by Sepsis

C5a Regulates Il-12(+)Dc Migration To Induce Pathogenic Th1 And Th17 Cells In Sepsis

Autocrine Regulation of Interleukin-3 in the Activity of Regulatory T Cells and Its Effectiveness in the Pathophysiology of Sepsis

Maintaining immune homeostasis with Coptis Chinensis water extract to mitigate sepsis severity via modulating gut microbiome and metabolism

CIRP increases Foxp3 + regulatory T cells and inhibits development of Th17 cells by enhancing TLR4-IL-2 signaling in the late phase of sepsis

Complement C3 Depletion Compromises the Outcomes of Human Abdominal Sepsis: a Link to the Expansion of Regulatory T Cells

Septic Macrophages Induce T Cells Immunosuppression in a Cell-Cell Contact Manner with the Involvement of CR3

Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis